WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010136163) SECERNIN-1 AS A MARKER FOR CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/136163    International Application No.:    PCT/EP2010/003139
Publication Date: 02.12.2010 International Filing Date: 21.05.2010
Chapter 2 Demand Filed:    03.03.2011    
IPC:
G01N 33/574 (2006.01)
Applicants: ROCHE DIAGNOSTICS GMBH [DE/DE]; Sandhofer Strasse 116 68305 Mannheim (DE) (DE only).
F. HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse 124 CH-4070 Basel (CH) (AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BE, BF, BG, BH, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CL, CM, CN, CO, CR, CU, CY, CZ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GT, GW, HN, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, ME, MG, MK, ML, MN, MR, MT, MW, MX, MY, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, ST, SV, SY, SZ, TD, TG, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, ZA, ZM, ZW only).
WILD, Norbert [DE/DE]; (DE) (For US Only).
HAGMANN, Marie-Luise [DE/DE]; (DE) (For US Only).
KARL, Johann [DE/DE]; (DE) (For US Only).
RIEDLINGER, Julia [DE/DE]; (DE) (For US Only).
ROESSLER, Markus [DE/DE]; (DE) (For US Only).
TACKE, Michael [DE/DE]; (DE) (For US Only)
Inventors: WILD, Norbert; (DE).
HAGMANN, Marie-Luise; (DE).
KARL, Johann; (DE).
RIEDLINGER, Julia; (DE).
ROESSLER, Markus; (DE).
TACKE, Michael; (DE)
Common
Representative:
ROCHE DIAGNOSTICS GMBH [DE/DE]; NASER, Werner Patent Department (TR-E) Postfach 11 52 82372 Penzberg (DE)
Priority Data:
09161524.5 29.05.2009 EP
Title (EN) SECERNIN-1 AS A MARKER FOR CANCER
(FR) SÉCERNINE-1, EN TANT QUE MARQUEUR DU CANCER
Abstract: front page image
(EN)The present invention relates to a method aiding in the assessment of cancer. It discloses the use of the Secemin-1 protein (= SCRN1) as a universal marker of different cancer types. Furthermore, it especially relates to a method for assessing cancer from a liquid sample, derived from an individual by measuring SCRN1 in said sample. Measurement of SCRN1 can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery.
(FR)La présente invention porte sur un procédé qui aide à l'évaluation du cancer. Elle décrit l'utilisation de la protéine sémécine-1 (SCRN1) en tant que marqueur universel de différents types de cancer. Elle porte en outre sur un procédé d'évaluation d'un cancer à partir d'un échantillon liquide, obtenu d'un individu, par mesure du SCRN1 dans ledit échantillon. On peut utiliser par exemple la mesure du SCRN1 au cours de la détection précoce d'un cancer, ou pour la surveillance de patients subissant une intervention chirurgicale.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)